801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsOral Medications

Anti Depressant Drugs Oral Medications Escitalopram Oxalate Tablets 10 mg

Anti Depressant Drugs Oral Medications Escitalopram Oxalate Tablets 10 mg

Anti Depressant Drugs Oral Medications Escitalopram Oxalate Tablets 10 mg

Product Details:

Place of Origin: China
Brand Name: Newlystar
Certification: GMP
Model Number: 5mg, 10mg, 20mg

Payment & Shipping Terms:

Minimum Order Quantity: 300, 000 tablets
Price: Negotiation
Packaging Details: 14’s/blister
Delivery Time: 45days
Payment Terms: L/C, T/T
Supply Ability: one million pills per day
Contact Now
Detailed Product Description
Product: Escitalopram Oxalate Tablets Specification: 5mg, 10mg, 20mg
Standard: BP, USP Packing: 14’s/blister

Anti Depressant Drugs Oral Medications Escitalopram Oxalate Tablets 10 mg

 

 

Product : Escitalopram Oxalate Tablets

Specification : 5mg, 10mg, 20mg

Standard : BP, USP

Packing : 14’s/blister

 

Description :

Escitalopram tablets are film-coated, round tablets containing escitalopram oxalate in strengths equivalent to 5 mg, 10 mg and 20 mg escitalopram base.

Escitalopram tablets should be administered once daily, in the morning or evening, with or without food.

 

Indications and Usage

1.1 Major Depressive Disorder

Escitalopram tablets are indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age.

A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation.

1.2 Generalized Anxiety Disorder

Escitalopram tablets are indicated for the acute treatment of Generalized Anxiety Disorder (GAD) in adults.

Generalized Anxiety Disorder (DSM-IV) is characterized by excessive anxiety and worry (apprehensive expectation) that is persistent for at least 6 months and which the person finds difficult to control. It must be associated with at least three of the following symptoms: restlessness or feeling keyed up or on edge, being easily fatigued, difficulty concentrating or mind going blank, irritability, muscle tension and sleep disturbance.

 

Pharmacodynamics

Escitalopram is one of a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). It is used to treat the depression associated with mood disorders. It is also used on occassion in the treatment of body dysmorphic disorder and anxiety. The antidepressant, antiobsessive-compulsive, and antibulimic actions of escitalopram are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin. In vitro studies show that escitalopram is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake. Escitalopram has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of escitalopram was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Escitalopram does not inhibit monoamine oxidase.

 

Mechanism of action

The antidepressant, antiobsessive-compulsive, and antibulimic actions of escitalopram are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin. Escitalopram blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT1A autoreceptors. SSRIs bind with significantly less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs.

Contact Details
Newlystar (Ningbo) Medtech Co.,Ltd.

Contact Person: Luke Liu

Send your inquiry directly to us (0 / 3000)